Tech Company Financing Transactions
Vitreo Retinal Technologies Funding Round
Vitreo Retinal Technologies, operating out of Irvine, raised $12 million from De Novo Ventures and private investors.
Transaction Overview
Company Name
Announced On
10/30/2007
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
2 Venture 430
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Vitreo Retinal Technologies, Inc. is a California Corporation, founded in July 1999 to discover, develop, and commercialize novel therapeutic and diagnostic systems for the treatment of serious ocular diseases. Since its founding VRT's primary objective has been in the areas of vitreoretinal diseases and ophthalmic surgery which are some of the leading causes of adult blindness in the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hampar Karageozian
Chief Operating Officer
Ramgopal Rao
Chief Technical Officer
Vicken Karageozian
VP - Manufacturing
John Park
Browse more venture capital transactions:
Prev: 10/30/2007: Curbed.com venture capital transaction
Next: 10/30/2007: Dataupia venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs